ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 57 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $202,307 | -37.4% | 12,804 | -40.0% | 0.00% | – |
Q2 2023 | $323,031 | -52.8% | 21,336 | -54.8% | 0.00% | – |
Q1 2023 | $684,055 | -87.4% | 47,176 | -88.3% | 0.00% | -100.0% |
Q4 2022 | $5,435,570 | -23.4% | 402,039 | -10.7% | 0.00% | -50.0% |
Q3 2022 | $7,092,000 | +30.7% | 449,993 | +1.0% | 0.00% | +100.0% |
Q2 2022 | $5,428,000 | +29.8% | 445,686 | +0.1% | 0.00% | 0.0% |
Q1 2022 | $4,183,000 | -45.1% | 445,455 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $7,626,000 | – | 445,455 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,425,784 | $75,769,000 | 16.37% |
5AM Venture Management, LLC | 4,408,379 | $75,471,000 | 14.16% |
72 Investment Holdings, LLC | 509,024 | $8,714,000 | 7.73% |
TCG Crossover Management, LLC | 663,694 | $11,362,000 | 5.32% |
Redmile Group, LLC | 1,954,420 | $33,460,000 | 0.76% |
StepStone Group LP | 761,277 | $13,033,000 | 0.74% |
Baker Brothers Advisors | 4,704,419 | $80,540,000 | 0.39% |
Avidity Partners Management LP | 255,000 | $4,366,000 | 0.09% |
MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,798,000 | 0.04% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 106,000 | $1,815,000 | 0.04% |